证券代码：688012 证券简称：中微公司 公告编号：2025-046 中微半导体设备（上海）股份有限公司 2024年年度权益分派实施公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容的 真实性、准确性和完整性依法承担法律责任。 重要内容提示： 每股现金红利0.30元 截至股权登记日下午上海证券交易所收市后，在中国证券登记结算有限责任公司上海分公司（以下简 称"中国结算上海分公司"）登记在册的本公司全体股东。（中微公司回购专用证券账户除外） 根据《中华人民共和国公司法》《中华人民共和国证券法》《上海证券交易所上市公司自律监管指引第 7号一一回购股份》等相关法律、行政法规、部门规章及其他规范性文件以及《公司章程》的有关规 定，公司回购专用证券账户中的股份不享有股东大会表决权、利润分配、公积金转增股本、认购新股等 权利。 3.差异化分红方案： ● 相关日期 ■ 一、通过分配方案的股东大会届次和日期 本次利润分配方案经公司2025年5月28日的2024年年度股东大会审议通过。 二、分配方案 1.发放年度：2024年年度 2.分派对象： （1）本次差异化分红方案 根据公司2 ...

沪深两市全天主力资金净流入71.38亿元，其中，科创板主力资金净流出3.23亿元，主力资金净流入的有 233只股，主力资金净流出的有355只股。 证券时报•数据宝统计显示，今日科创板个股上涨的有452只，涨停的有泰凌微等1只，下跌的有126只。 资金流向方面，今日主力资金净流入的科创板股共有233只，其中，5只个股主力资金净流入超亿元，寒 武纪主力资金净流入3.62亿元，净流入资金居首；中芯国际、泰凌微紧随其后，全天净流入资金分别为 3.49亿元、1.07亿元。主力资金净流出的有355只，净流出资金最多的是广大特材，该股今日上涨 2.91%，全天主力资金净流出1.58亿元，其次是联赢激光、仕佳光子，主力资金净流出分别为1.33亿 元、1.24亿元。 从主力资金连续性进行观察，共有62只个股主力资金连续3个交易日以上持续净流入，连续流入天数最 多的是三友医疗，该股已连续10个交易日净流入；连续净流入天数较多的还有特宝生物、正帆科技等， 主力资金分别连续流入9天、8天。主力资金连续流出的个股有114只，连续流出天数最多的是博汇科 技，该股已连续24个交易日净流出；连续净流出天数较多的还有芯联集成、中微半导等，主力 ...

机构上调多只半导体及食品饮料个股评级 智通财经6月1日电，据统计，5月内71家机构合计进行了5151次评级，共计1859只个股被券商研报给 予"买入型"评级（包括买入、增持、强烈推荐、推荐）。从评级调整来看，多股获得机构上调评级。分 行业来看，半导体板块多股上榜，包括中微半导、盛科通信、伟测科技、纳芯微等。此外，部分食品饮 料股也获得评级上调，包括莲花控股、百润股份、东鹏饮料等。上述个股最新评级均为"买入"。 (证券 时报) ...

Investment Rating - The investment rating for the company is "Add" and is maintained [1] Core Insights - The company has shown steady revenue growth and has turned losses into profits. In 2024, the demand in the MCU sector continues to rise, but due to intensified competition, product prices are declining, leading to a decrease in overall market revenue. The global MCU market sales are projected to be $22.4 billion in 2024, down from the previous year by $5.6 billion. Despite these challenges, the company has improved its product competitiveness through new product development and effective supply chain management, resulting in a nearly 50% year-on-year increase in shipment volume and a 27.76% increase in revenue to 912 million yuan. The gross margin has significantly improved to 29.86%, with a net profit of 137 million yuan [4][5] Company Overview - The latest closing price of the company's stock is 25.92 yuan. The total share capital is 400 million shares, with a circulating share capital of 148 million shares. The total market value is 10.4 billion yuan, and the circulating market value is 3.8 billion yuan. The stock has a 52-week high of 34.64 yuan and a low of 15.22 yuan. The asset-liability ratio stands at 9.5%, and the price-to-earnings ratio is 76.24 [3] Financial Forecast and Metrics - The company is expected to achieve revenues of 1.24 billion yuan, 1.56 billion yuan, and 1.96 billion yuan in 2025, 2026, and 2027 respectively, with net profits of 180 million yuan, 240 million yuan, and 330 million yuan for the same years. The projected growth rates for revenue are 36.36%, 25.09%, and 25.79% respectively. The gross margin is expected to improve to 34.8% in 2025 and further in subsequent years [6][8]

Core Insights - The company has shown steady revenue growth and has turned losses into profits, with a projected revenue of 912 million yuan in 2024, representing a year-on-year increase of 27.76% [2] - The global MCU market is expected to decline in sales by 5.6 billion dollars in 2024, reaching a total of 22.4 billion dollars, due to intensified competition and falling product prices [2] - The company is focusing on R&D and expanding its product applications, with R&D expenses of 128 million yuan in 2024, accounting for 13.99% of revenue [3] Financial Performance - The company achieved a gross margin of 29.86% in 2024, with a net profit of 137 million yuan [2] - In Q1 2025, the company reported revenue of 206 million yuan, with a gross margin of 34.46% and a net profit of 34 million yuan, reflecting a year-on-year increase of 19.4% [2] - Future revenue projections for 2025, 2026, and 2027 are 1.24 billion yuan, 1.56 billion yuan, and 1.96 billion yuan respectively, with net profits of 180 million yuan, 240 million yuan, and 330 million yuan [4] R&D and Market Strategy - The company maintains a high level of R&D investment, with a focus on developing general-purpose MCU products, successfully transitioning from specialized to a mix of specialized and general-purpose MCUs [3] - The expansion into new application areas, such as AI servers and robotics, has effectively broadened the market space for the company's products [3]

Investment Rating - The investment rating for the company is "Add" and is maintained [1] Core Views - The company has shown steady revenue growth and has turned losses into profits. In 2024, the demand in the MCU sector continues to rise, but due to intensified competition and declining product prices, the overall market revenue is expected to decrease. The global MCU market sales are projected to be $22.4 billion, a year-on-year decline of $5.6 billion. Despite these challenges, the company has improved its product competitiveness through new product development and effective supply chain management, resulting in a nearly 50% year-on-year increase in shipment volume and a 27.76% increase in revenue to 912 million yuan. The gross margin has significantly improved to 29.86%, with a net profit of 137 million yuan [4][5] Company Overview - The latest closing price of the company's stock is 25.92 yuan. The total share capital is 400 million shares, with a circulating share capital of 148 million shares. The total market value is 10.4 billion yuan, and the circulating market value is 3.8 billion yuan. The 52-week high and low prices are 34.64 yuan and 15.22 yuan, respectively. The asset-liability ratio stands at 9.5%, and the price-to-earnings ratio is 76.24 [3] Financial Forecast and Key Indicators - The company is expected to achieve revenues of 1.24 billion yuan, 1.56 billion yuan, and 1.96 billion yuan in 2025, 2026, and 2027, respectively. The net profit attributable to the parent company is projected to be 180 million yuan, 240 million yuan, and 330 million yuan for the same years. The report maintains an "Add" rating [6][8]

Core Viewpoint - The company announced the cancellation of part of the 2023 restricted stock incentive plan due to the departure of certain incentive targets and unmet performance goals, resulting in a total of 1,310,000 shares being voided [6][7][8]. Summary by Sections 1. Procedures of the Equity Incentive Plan - The company held a board meeting on April 24, 2023, to approve the draft of the 2023 restricted stock incentive plan and related matters [1]. - The supervisory board verified the related matters and issued relevant opinions during a meeting on April 26, 2023 [2]. - The company publicly announced the list of incentive targets on May 10, 2023, with no objections received during the public notice period [3]. - The annual general meeting on May 18, 2023, approved the relevant proposals, and a self-inspection report regarding insider trading was disclosed on May 19, 2023 [4]. - Subsequent meetings in June 2023 and June 2024 approved adjustments and the granting of restricted stocks to incentive targets [5]. 2. Specifics of the Canceled Restricted Stocks - The cancellation was due to the departure of 7 incentive targets, resulting in 105,074 shares being voided [6]. - Additionally, 1,204,926 shares were voided because the company's 2024 performance did not meet the established targets, leading to a total cancellation of 1,310,000 shares [7][8]. - Following this cancellation, the number of incentive targets decreased from 124 to 117, and the total number of restricted stocks in the plan reduced from 3,318,210 to 2,008,210 shares [8]. 3. Impact of the Canceled Stocks - The cancellation of the restricted stocks is not expected to have a significant impact on the company's financial status or operational results, nor will it affect the stability of the management team or the ongoing implementation of the equity incentive plan [9]. 4. Special Opinions - The supervisory board confirmed that the cancellation complies with relevant laws and regulations, and does not harm shareholder interests [10]. - Legal opinions indicated that the necessary approvals and procedures for the cancellation were followed, aligning with regulatory requirements [10].

证券代码：688380 证券简称：中微半导 公告编号：2025- 016 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 中微半导体（深圳）股份有限公司（以下简称"公司"）于2025年5月28日 召开第二届董事会第二十三次会议及第二届监事会第二十次会议，审议通过了 《关于作废处理2023年限制性股票激励计划部分限制性股票的议案》，现将相 关情况公告如下： 1、2023 年 4 月 24 日，公司召开了第二届董事会第三次会议，会议审议 通过了《关于公司〈2023 年限制性股票激励计划（草案）〉及其摘要的议 案》《关于公司〈2023 年限制性股票激励计划实施考核管理办法〉的议案》 《关于提请股东大会授权董事会办理公司 2023 年限制性股票激励计划相关事 宜的议案》，公司独立董事就本激励计划相关议案发表了独立意见。 同日，公司召开第二届监事会第二次会议，会议审议通过上述相关议 案，并对本激励计划的相关事项进行核实且出具了相关核查意见。 2、2023 年 4 月 26 日，公司于上海证券交易所网站（www.sse.com.cn） ...

证券代码：688380 证券简称：中微半导 公告编号：2025-015 中微半导体（深圳）股份有限公司 2024年年度股东大会决议公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 本次会议是否有被否决议案：无 一、 会议召开和出席情况 （一） 股东大会召开的时间：2025 年 5 月 28 日 （二） 股东大会召开的地点：深圳市前海深港合作区南山街道桂湾三路 91 号前 海金融中心 T1 栋 21 楼会议室 （三） 出席会议的普通股股东、特别表决权股东、恢复表决权的优先股股东及 其持有表决权数量的情况： | 1、出席会议的股东和代理人人数 | 170 | | --- | --- | | 普通股股东人数 | 170 | | 2、出席会议的股东所持有的表决权数量 | 286,039,826 | | 普通股股东所持有表决权数量 | 286,039,826 | | 3、出席会议的股东所持有表决权数量占公司表决权数量的比 | 71.71 | | 例（%） | | | 普通股股东所持有表决权数量占公司表决权数量的比例 ...

北京盈科(成都)律师事务所 关于中微半导体(深圳)股份有限公司 2024年年度股东大会的 [2025] 盈成 象,字第475号 法律意见书 北京盈科(成都)律师事务所 JING YINGKE LAW FIRM CHENGDU OFFICE 四川省成都市高新区交子大道 177 号中海国际中心 B 座 20-22 层 二〇二五年五月 法律意见书 > 盈科律师事务所 北京盈科(成都)律师事务所 关于中微半导体(深圳)股份有限公司 2024年年度股东大会的法律意见书 致:中微半导体(深圳)股份有限公司 北京盈科(成都)律师事务所(以下简称"本所")是具有中华人民共和国法 律执业资格的律师事务所。本所接受中微半导体(深圳)股份有限公司(以下简 称"公司"）的委托,就公司召开 2024年年度股东大会(以下简称"本次股东大会") 的有关事宜,根据《中华人民共和国公司法》(以下简称"《公司法》")、《中 华人民共和国证券法》(以下简称"《证券法》")、《上市公司股东会规则》(以 下简称"《股东会规则》")等法律、法规、规章及其他规范性文件(以下简称"中 国法律法规",仅为本法律意见书之目的,不包括香港特别行政区、澳门特别行 ...